 I
???????????????? ???? 
 
???????????????????????? 
The Development of Quantitative Assessment Techniques for Diagnosis and Cognition 
Functions of Prognosis during Acute Phase in Stroke Patients 
?????NSC95-2221-E-035-004 
           ?????95 08 01?? 96? 07? 31? 
???????          
?????????           
?????????? ???           
 
?? 
??????????????????????????????????????
?????????????????????????????????? 2~4 ????
????????????????????????????????????????
????????????????????????????????????????
????????????????????????????????????????
?????????????????????????????10??????????
???????(????????=56.4?11.9?)??????? Cozaar?????????
????????????????????????????????????????
????????????? MABP(???? 127.55?31.21 mmHg????? 86.68?9.28 
mmHg, p<0.05)??????? MCBFV(???? 71.38?35.68 cm/s????? 68.71?26.41 
cm/s)??????????????????????????????????????
????????????????????????????????????????
????????????????????????????????????????
????????????????????????????????????????
???? 
 
????????????????????????????????? 
???? 
??????????????????????[1]????????????????
??????????????????????????????????????? 2~4
????????????????????????????????????????
(cerebral autoregulation, CA)?????????????????????????????
??????CA ?????????????????????????????????
?????????????????????????????????????????
?????????????????????????????????????????
??????????????????????????????????????(???
???????????)??????????????????????????????
?????????????????????????????????????????
???????????????????? 
?????? 
???????????????????????????????????????
?????????????????????????????????????????
?????????????????????????????????????????
?????????????????????????????????????????
?????????????????????????????????????????
?????????????????????????????????????????
?????????????????????????????????????????
?????????????????????????????????????????
?????????????????????????????????????????
?????????????????????????????????????????
??????????????? 
?????? 
??????????? 1937? Fog ??[2]? Lassen? 1959???????????
???????????? 50~170mmHg????????????????[3]?Tiecks??
? 1995 ???????????????????????????????[4]?Panerai ?
?? 1995 ??????????????[5]??????????????(transfer function 
analysis)????????????????[6-8]????????????Kuo ??? 1998
?? Chen??? 1999?????????????????????????(0.04~0.15Hz)
?? 2.1 ????[9-10]?Kagiyma ??? 1999 ????????????????????
???????[11]?Panerai??? 2000???????? CO2????????[12]???
?????? 2001?????????(cross-correlation analysis)?????????????
???????????????????????[13]????????????????
??????????????????????????????????????
[14-15]?????????????????????????[16-17]??????????
?????????????????????????? 
 2
???????????????PI?????????:  
MCBFV
DCBFVSCBFVPI −=                                                  ?4? 
?? SCBFV: systolic cerebral blood flow velocity, DCBFV: diastolic cerebral blood flow velocity, 
MCBFV: mean cerebral blood flow velocity 
 
(3)?????(cerebrovascular resistance, CVR) [20]:?????????????????
?????????? mmHg/(cm/s)?CVR?????????:  
MCBFV
MABPCVR =                                                          ?5? 
?? MABP: mean arterial blood pressure, MCBFV: mean cerebral blood flow velocity  
C.??????????? (Dynamic Autoregulatory Index, ARI) 
???????????(ARI)?????????????????????????
????????????????????????????????????????
??????????????????????????????????????(ARI)
??????[21-22]: 
1.???????????????, )(tP  
CrCPP
PtPtdP
M
M
−
−= )()(                                                      ?6? 
(6)?? MP ? )(tP ?????CrCP??????(Critical closing pressure)????? Tiecks [21]
? Panerai [22]????CrCP =12 mmHg? 
2.???????????, )(tVT  
)(tVT = ))()(1( 2 tKxtdPVM −+                                                 ?7? 
(7)??K???????(autoregulatory gain parameter)? MV ?????????????
)(2 tx ?????(state variable)??(8)??? )(2 tx ? 
fT
tDxtxtxtx )1(2)()1()( 2122
−−+−=                                            ?8? 
(8)??? )(1 tx ??(9)??? 
fT
txtdPtxtx )1()()1()( 211
−−+−=                                              ?9? 
(8)?(9)?? f :????(sampling frequency), D :????(damping factor), T :????(time 
constant)???????? f ? 60Hz, T , D , K????????? ARI?????[21]: 
 
3.????????(standard error, SE) 
???????????? )(tVR ? ARI 0~9??????? )(tVT ??????????
????? ARI?????? 
)()()( tVtVtx TRk −= …                                                    ?10? 
:t 1,2,…N? :k 0,1,…..9 
(10)?? )(txk ??????????????????? )(tVR ????????? )(tVT
????????? N :????? t? time index? k? ARI?? 
 4
?? y(n)?? x(n)?????????????? )(ˆ nx ?y(n) ??????????????
)(ˆ ny ???????????????????????????????????????
??????????????????????????? CCF ???????????
CCF ???????????????????????????????????????
?????????? 
[ ]21)0()0(
)(
)(
ˆˆˆˆ
ˆˆ
i
yy
i
xx
i
yx
i
RR
kR
kCCF = , ,,2 ,1 ,0 L±±=k  i=1 to N-W+1 



∑ =−
∑ =+
= +
=
+
=
Wi
ij
Wi
iji
yx
kjykjx
W
kkjyjx
WkR
L
L
,2- ,1- ,0 ),(ˆ)(ˆ1
,2 ,1 ,0 ),(ˆ)(ˆ1
)(ˆˆ  
∑= +
=
Wi
ij
i
xx jxW
R 2ˆˆ )](ˆ[
1)0( , and ∑= +
=
Wi
ij
i
yy jyW
R 2ˆˆ )](ˆ[
1)0( .                 (17) 
?(17)????????????? CCF?k????????? CCF?k???????
????????????????????????????????????????
????? 
???? 
A.???????Power spectral density analysis?[30] 
???????????????????????????????????????
?????????????????????????????????????????
????????????????????????????????????????? x
???????????y?????????????????????(Fast fourier transform, 
FFT)?????????????? 
???? x(t)????? x(n)????? FFT????????? 
∑−
=


−=
1
0
2exp)()(
N
n
kn
N
jnxTkX π  
??????? 
)()(1)(1)( *2 kXkX
NT
kX
NT
kS xx ==                    (18) 
??*??????N???????T?????? 
B.?????? (Transfer function analysis) ??????Coherence function?[31-32] 
???????????????????????????????????????
?????????????????????????????????????????
??(linearity)???????????????????????????????????
?????????????????????? 0.7??????????????????
????????? 
 6
M0-pre:????M0-drug:??? 3???M3:??? 3???!p<0.05 (MCBFV M0-pre supine vs. tilting position), 
@p<0.05 (DCBFV M0-pre supine vs. tilting position), #p<0.05 (SCBFV M0-drug supine vs. tilting position), $p<0.05 
(MCBFV M0-drug supine vs. tilting position), ^p<0.05 (DCBFV M0-drug supine vs. tilting position), *p<0.05 (MABP 
M3 supine vs. tilting position), a p<0.05 (SCBFV M3 supine vs. tilting position), b p<0.05 (MCBFV M3 supine vs. tilting 
position), c p<0.05 (DCBFV M3 supine vs. tilting position),?p<0.05 (SABP M0-pre vs. M3 in supine position), ?
p<0.05 (SABP M0-drug vs. M3 in supine position),?p<0.05 (MABP M0-pre vs. M3 in supine position),?p<0.05 
(MABP M0-drug vs. M3 in supine position),?p<0.05 (DABP M0-pre vs. M3 in supine position),?p<0.05 (DABP 
M0-drug vs. M3 in supine position),?p<0.05 (SABP M0-pre vs. M3 in tilting position),?p<0.05 (SABP M0-drug vs. M3 
in tilting position),?p<0.05(MABP M0-pre vs. M3 in tilting position),?p<0.05 (MABP M0-drug vs. M3 in tilting 
position),?p<0.05(DABP M0-pre vs. M3 in tilting position),?p<0.05 (DABP M0-drug vs. M3 in tilting position). 
 
????(resistance index, RI)?????(pulsatility index, PI)??????(cerebrovascular 
resistance, CVR)?????? 
?????????????????????????????????????????
PI???????????????????(p<0.05)??????? PI ,CVR???????
??????????(p<0.05)??????? RI, PI, CVR???????????????
??????(p<0.05)????????????????????????????????
?????????????????????????????????????????
?????????????????????????????????????????? 
??:????????????? 
M0-pre:????M0-drug:???3???M3:???3???@p<0.05(PI M0-pre supine vs. tilting), # p<0.05(PI M0-drug 
supine vs. tilting), ^p<0.05(CVR M0-drug supine vs. tilting), & p<0.05(RI M3 supine vs. tilting), * p<0.05(PI M3 supine 
vs. tilting), ! p<0.05(CVR M3 supine vs. tilting) 
SABP MABP  DABP mmHg 
Supine Tilting Supine Tilting Supine Tilting 
M0-pre 176.33?20.29? 176.90?43.58? 127.56?19.07? 127.55?31.21? 100.56?18.96? 103.18?26.20?
M0-drug 168.68?23.05? 167.71?23.61? 119.18?15.54? 118.53?15.27? 93.65?13.53? 95.23?13.99?
M3 126.21?11.22 118.73?8.46 92.84?10.50* 86.68?9.28 75.22?10.95 72.02?11.41 
SCBFV MCBFV DCBFV cm/s 
Supine Tilting Supine Tilting Supine Tilting 
M0-pre 122.36?58.69 116.24?5.35 77.59?38.83! 71.38?35.68 47.17?24.34@ 41.39?23.15 
M0-drug 128.46?64.41# 116.73?59.97 79.80?41.66$ 69.97?35.58 48.25?25.85^ 37.14?16.16 
M3 119.34?42.07a 109.83?39.05 79.08?27.79b 68.71?26.41 53.22?27.29c 45.08?24.96 
RI PI CVR  
Supine Tilting Supine Tilting Supine Tilting 
M0-pre 0.61?0.08 0.65?0.08 0.99?0.22@ 1.08?0.25 2.03?1.05 2.19?1.13 
M0-drug 0.63?0.07 0.67?0.08 1.02?0.18# 1.13?0.25 1.91?1.04^ 2.10?1.03 
M3 0.57?0.12& 0.61?0.13 0.91?0.34* 1.02?0.37 1.33?0.48! 1.42?0.47 
 8
?????? (Cross-Correlation Analysis) 
?????????(CCF)??????????? 3 ??????????? CCF ?(max 
CCF value)??? CCF?(max CCF value)??? CCF?(max CCF value)?Max CCF value ??
??????????????????? max CCF value??????(supine:M0-pre: 0.31±
0.19, M0-drug: 0.35±0.16, M3: 0.37±0.22; tilting: M0-pre: 0.26±0.16, M0-drug: 0.30±0.16, M3: 0.45±
0.12)????????????????????(p<0.05)????????? max CCF value
????????????????(0.30±0.15)???????????(0.34±0.16) ????
??????????????(p<0.05)????????????????????????
?????????????????????????????????????????
????????? 
 
???????????????????? 
 Max CCF value Max CCF index Max CCF time (sec)
Supine 0.31?0.19 -1.56?3.94 -1.66?3.47 
LF(0.07-0.15Hz) 
Tilting 0.26?0.16@ -2.98?3.27 -2.71?3.05 
Supine 0.16?0.09^ -1.00?1.50 -1.91?1.42 
M0-pre 
HF(0.15-0.4Hz) 
Tilting 0.29?0.19 -0.68?1.35 -0.68?1.29 
Supine 0.35?0.16 -3.45?2.33 -3.12?1.94* 
LF(0.07-0.15Hz) 
Tilting 0.30?0.16# -1.54?2.28 -1.45?2.15 
Supine 0.26?0.17 -1.63?1.74? -1.52?1.61? 
M0-drug 
HF(0.15-0.4Hz) 
Tilting 0.26?0.20& -0.40?0.52? -0.34?0.45? 
Supine 0.37?0.22 -1.81?2.04 -1.56?1.55* 
LF(0.07-0.15Hz) 
Tilting 0.45?0.12@# -1.09?1.29 -1.06?1.13 
Supine 0.30?0.15^? -0.57?1.07 -0.52?0.95 
M3 
HF(0.15-0.4Hz) 
Tilting 0.47?0.18&? -0.11?0.33 -0.11?0.33 
M0-pre:????M0-drug:??? 3???M3:??? 3??, @p<0.05 (M0-pre vs M3 in LF, max CCF value in tilting 
position), #p<0.05 (M0-drug vs M3 in LF, max CCF value in tilting position), *p<0.05 (M0-drug vs M3 in LF, max CCF 
time in supine position), ^p<0.05 (M0-pre vs M3 in HF, max CCF value in supine position), &p<0.05 (M0-drug vs M3 in 
HF, max CCF value in tilting position), ?p<0.05 (M0-drug, supine vs tilting in HF, max CCF index in tilting position), 
?p<0.05 (M0-drug, supine vs tilting in HF, max CCF time in tilting position), ?p<0.05 (M3, supine vs tilting in HF, 
max CCF value in tilting position) 
 
????????? 
?????????????????MABP?????????????????????
?????????????????????????????????????????
??????????????????(p<0.05)????????????????????
???(p<0.05)?MCBFV??????????????????????????????
?????????????????????????????????????????
??? 
 10
????(pulse wave velocity) 
10???????????????????????? 3?????????????
??????(p?0.05)?????????????????????????????
???????????????????????????????????????
???????????????????????????????????????
??????????????????????????????????????? 
??:10???????????? 
 Pulse wave velocity (m/s) 
 
Heart rate (beat/min) PWV(1) PWV(2) PWV(3) average 
M0 74.93?13.81 9.15?1.38 9.08?1.23 9.07?1.33 9.42?1.27 
M3 76.07?10.16 9.16?1.21 9.15?1.47 9.08?1.39 9.50?1.20 
M6 74.79?12.47 9.14?1.07 9.16?1.27 9.12?1.25 9.32?1.10 
PWV(1):??????PWV(2):??????PWV(3):??????M0-pre:???? 
M3:??? 3???M6:??? 6?? 
 
??????(cognition function) 
???????????????????????????????????????? 
NIHSS, Barthel ? MRS ??????????????(p<0.05)?????????????
???????????????? 
 
??:10???????????? 
Cognition function assessment 
 
NIHSS Barthel MRS CASI MMSE 
M0 2.75?9.56# 73.89?23.82^ 2.56?1.42* 75.71?18.05 21.71?5.62 
M3 1.00?1.00 100.00?0. 0.67?0.5 81.11?11.17 24.33?3.08 
NIHSS: National Institutes of Health Stroke Scale, Barthel: Barthel index, MRS: Modified Rankin Scale, CASI: Cognitive 
Abilities Screening Instrument, MMSE: Mini Mental State Examination.. # p<0.05 (NIHSS M0 vs. M3), ^ p<0.05 (Barthel 
M0 vs. M3), * p<0.05 (MRS M0 vs. M3) 
 
???????? 
???????????????????????????????????????
?????????????????????????????????????????
?????????????????????????????????????????
?????????????????????????????????????????
?????????????????????????????? 
 
?????????????????????? 
1. ??????????? “???????????????????????????
 12
examination of autonomic nervous system Proc. of the Biomedical Engineering Society 1997  
Annual Symposium, 46-47.(???????NSC87-2213-E-035-033) 
[16] Y. Ogawa, K. Iwasaki, S. Shibata, J. Kato and S. Ogawa, and Y. Oi “The effect of sevoflurane on 
dynamic cerebral blood flow autoregulation assessed by spectral and transfer function analysis,” 
Anesthesia Analgesia, vol.102, pp. 552-559, 2006. 
[17]Mankovsky BN, Piolot R, Mankovsky OL, Ziegler D (2003) Impairment of cerebral 
autoregulation in diabetic patients with cardiovascular autonomic neuropathy and orthostatic 
hypotension. Diabetic Medicine. 20(2):119-126. 
[18] Z.X. Jiang, “The Assessment of Dynamic cerebral autoregulation in diabetes using linear  
analysis,” Master Thesis, Institute of Automatic Control Engineering, Feng Chia University,  
Taiwan, 2002 
[19] L.B. Viken et al., ?Transcranial Doppler Ultrasonography?, Boston: Butterworth-Heinemann, 
1999? 
[20] M.J. Hilz et al., “Reduced cerebral blood flow velocity and impaired cerebral autoregulation in 
patients with Fabry disease”, Journal of Neurology, vol:251, pp. 564-570, 2004. 
[21] Tiecks FP, Lam AM, Aaslid R and Newell DW (1995) Comparison of static and dynamic 
cerebral autoregulation measurements, Stroke, 26: 1014-1019. 
[22] Panerai RB, Eames PJ and Potter JF (2003) Variability of time-domain ondices of dynamic 
cerebral autoregulation, Physiological measurement, 24:367-381. 
[23] M.Soehle, M. Czosnyka, J.D. Pickard and P.J. Kirkpatrick, “Continuous assessment of cerebral 
autoregulation in subarachnoid hemorrhage”, Anesth analg, vol:98, pp. 1133-1139, 2004. 
[24] S.K. Piechnik, X. Yang, M. Czosnyka, P. Smielewski, S.H. Fletcher, A.L. Jones and J.D. Pickard, 
“The continuous assessment of cerebral activity: a validation of the method in healthy volunteers”, 
Neurosurgical anesthesia, vol:89, pp. 944-949, 1999. 
[25] C.C. Chiu, S.J. Yeh, and B.Y. Liau, 2005 June, “Assessment of Cerebral Autoregulation 
Dynamics in Diabetics Using Time-Domain Cross-Correlation Analysis”, Journal of Medical and 
Biological Engineering, vol. 25, No. 2, p. 53-59. (EI) 
[26] S.J. Yeh, B.Y. Liau, C.L. Shen, and C.C. Chiu, 2004 October, “Time-domain 
cross-correlation analysis of cerebral autoregulation in diabetic autonomic neuropathy”, Clinical 
Autonomic Research, vol. 14, No. 5, p. 322-323. (SCI) 
[27] S.J. Yeh, C.C. Chiu, 2002 August, “Cross-correlation analysis of cerebral autoregulation 
during sympathetic stimulation”, Clinical Autonomic Research, vol. 12, No. 4, p. 298. (SCI) 
[28] C.C. Chiu and S.J. Yeh, 2001 October, “Assessment of cerebral autoregulation using  
time-domain cross-correlation analysis”, Computers in Biology and Medicine, vol. 31, No. 6,  
pp. 471-480. (SCI, EI) 
[29] C.C. Chiu and S.J. Yeh, 2001 June, “Assessment of cerebral autoregulation under different 
sympathetic tests using time-domain cross-correlation analysis”, Journal of Cerebral Blood Flow 
and Metabolism, vol. 21, p. 210. (SCI) 
[30] R.M. Rangayyan, “Biomedical signal analysis: A case-study approach”, IEEE press, John Wiley 
& Sons, inc. 2002 
 14
???????????? 
? ?????  5 ?????                           ???96? 7? 31? 
??????? 
?????????????????????????????
????????? 
?????NSC95-2221-E-035-004  ????????? 
??/???? ???????????????????????? 
???/??? ??? 
?????????????? LabVIEW????????
??????????(Finpres? TCD)????????????
?????????????????????????????
??????????????????????????? 
 
 
 
???? The noninvasive assessment is adopted and developed using 
LabVIEW environment to be the analytic system. Blood pressure and 
cerebral blood flow velocity signals are acquired using Finapres and 
TCD. These signals are applied to different approaches to evaluate the 
function of cerebral autoregulation. The results can be helpful for 
clinical trreamtnt. 
?????? 
? 
?????? 
???? 
???? 
?????????????????????????????
???????????????? 
????????
?????????????????????? 
※ 1.????????????????????????????? ?????
???????????????? 
※ 2.????????????????????????????? 
※ 3.???????????????? 
 1
?????????????????????
?????????????????????
?[9~14]??????????????????
?????????????????????
?????????????????????
?????????????????????
?????????????????????
?????????????????????
??????? 
 
??????? 
10 ??????????????????
(????=56.4?11.9?)???????????
???????????? TCD (transcranial 
Doppler, EME TC2020)???????????
?????????????????? Finapres 
(Ohemda 2300)??????????????
?????????????????????
???????????????? 11????
(????=56.5?8.6 ?)???????????
?????????????????????
?????????????????????
????????? LabVIEW ???????
???????????????(mean arterial 
blood pressure, MABP)??????? (mean 
cerebral blood flow velocity, MCBFV)??????
????????? 
 
1.???? 
)(⋅ABP ?? Finapres ???????????
???? iABP?? i????????????N
?????? i????????? i+1????
?????????? (1)????????
?MABP??? 1??????????????
(2)? )(⋅CBFV ? TCD????????????
iCBFV ?? i????????????N???
??? i????????? i+1???????
??????? (2)?????????
?MCBFV?? 
 
∑+
=
=
1
)(1
i
ik
ii kABPN
MABP  ….….…….….(1) 
 
 
 
 
 
 
 
 
? 1. ????????? 
 
∑+
=
=
1
)(1
i
ik
ii kCBFVN
MCBFV ………..….…(2) 
2.?????? (cross-correlation function, CCF) 
????????????????????
??MABP?????????MCBFV????
?????????????????????
?????????????????????
?????? CCF?k??W???????k?
????????????N ????????
?????????? MABP ???????
x(n)? MCBFV??????? y(n)?? x(n)??
???????????? )(ˆ nx ?y(n) ????
?????????? )(ˆ ny ?????????
????????? 
 
[ ]21)0()0(
)(
)(
ˆˆˆˆ
ˆˆ
i
yy
i
xx
i
yx
i
RR
kR
kCCF = ….….…….….(3) 
 
k=0,?1,?2,… i=1 to N-W+1 
 
?? 



−−=−
=+
=
∑
∑
+
=
+
=
Wi
ij
Wi
ij
i
yx
kjykjx
W
kkjyjx
W
kR
2,1,0),(ˆ)(ˆ1
2,1,0),(ˆ)(ˆ1
)(ˆˆ  
1+iABPiABP
 3
? 2:?????????????MABP, 
MCBFV ???(M0-pre:????M0-drug:?
??????M3:??????) 
 
CCF ???????? 3 ?????????
????????????CCF???????
???????????????? CCF ?
(maximum CCF value)???? CCF ????
(maximum CCF time index)?????????
(corresponding time lag)???????????
CCF ??????????????????
?????????????????????
?????[9,13]? 
 
 
 
 
 
 
? 3:????? CCF?????k??????
CCF(k)? CCF?????(?)?????????
CCF????(?) ????????? CCF??
?? 
??????(CCF)?????? max CCF 
value ???(0.07~0.15 Hz)????????
?????? max CCF value ??????(?
4)(supine:M0-pre: 0.31 ?0.19, M3: 0.37 ?0.22, 
Normal: 0.57?0.13; tilting: M0-pre: 0.26?0.16, M3: 
0.45?0.12, Normal: 0.55?0.19 )?????????
???????????(p<0.05)??????
(0.15~0.4 Hz)???max CCF value??????
??????????(0.30?0.15)??????
?????(0.34?0.16) ???????????
???????(p<0.05)??????????
????????????????? max CCF 
time ???????????????????
???????????(p<0.05) (M0-drug: -3.12?
1.94, M3: -1.56?1.55, ???: -1.65?0.80)?????
?????????????????????
?????????????????????
???? 
?????????max CCF value ??(LF)
0
0.1
0.2
0.3
0.4
0.5
0.6
M0-pre M0-drug M3 Normal
m
a
x
 
C
C
F 
v
a
l
u
e
supine
tilting
 
?????????max CCF value ??(HF)
0
0.1
0.2
0.3
0.4
0.5
M0-pre M0-drug M3 Normal
m
a
x
 
C
C
F 
v
a
l
u
e
supine
tilting
 
? 4:????????????? max CCF 
value???(M0-pre:????M0-drug:??
?????M3:??????)  
 
???? 
 
???????????????????
?????????????????????
?????????????????????
????????????????????
?????????????????????
?????????????????????
?????????????????????
?????????????????????
?????????????????????
?????????????????????
?? 
???? 
 
? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
(NSC95-2221-E-035-004) ??????????
???? 
 
?????? 
[1]????????(http:// www.doh.gov.tw/) 
 5
??? 
 
A NOVEL APPROACH USING HIGHER ORDER CROSSINGS TO ASSESS 
DYNAMIC CEREBRAL AUTOREGULATION IN DIABETICS WITH AUTONOMIC 
NEUROPATHY  
 
Chuang-Chien Chiu*, Ben-Yi Liau*, Shoou-Jeng Yeh** 
*Institute of Electrical and Communications Engineering, Feng Chia University, Taichung, Taiwan, R.O.C. 
** Section of Neurology and Neurophysiology, Cheng-Ching General Hospital, Taichung, Taiwan, R.O.C. 
 
Abstract 
 
In this study, a novel approach using higher order crossings (HOC) analysis was applied to evaluate the 
relationship between blood pressure and cerebral blood flow velocity (CBFV) signals.  There were 66 
diabetics ( 14 diabetics without autonomic neuropathy, 25 diabetics with mild autonomic neuropathy and 17 
diabetics with severe autonomic neuropathy ) and 11 age-matched healthy adults for normal subjects being 
recruited in this study. Continuous cerebral blood flow velocity (CBFV) was measured in the middle cerebral 
artery using TCD ( Transcranial Doppler ultrasound , EME TC2020 ) in conjunction with a 5-MHz transducer 
fixed over the temporal bones by an elastic headband. Continuous arterial blood pressure (ABP) recordings 
were obtained through the Finapres (Ohmeda 2300) device with the cuff attached to the middle finger of the 
right hand. The results revealed that the zero-crossings values of both MABP and MCBFV in all normal 
subjects converge to a constant.  However, the zero-crossings values do not converge to a constant in diabetics. 
The values of zero-crossings between normal subjects and diabetics with severe autonomic neuropathy were 
significantly different (Mann-Whitney test , p ? 0.001 ). It might indicate that the cerebral autoregulation 
mechanisms in normal subjects are better than that in diabetics. Therefre, the HOC can be a useful tool to 
evaluate dynamic cerebral autoregulation in clinical practice. 
Keywords: Cerebral autoregulation (CA); Higher order crossings (HOC); Mean arterial blood 
pressure (MABP); Mean cerebral blood flow velocity (MCBFV). 
  
(The authors would like to thank the National Science Council, Taiwan, ROC, for supporting this research 
under contract no. NSC95-2221-E035-004)
 7
these results, it can be speculated that autonomic 
nervous system might be impaired in diabetics 
affecting autonomic control of peripheral and brain 
vessels. 
Keywords: Cerebral autoregulation (CA), detrended 
fluctuation analysis (DFA). 
 
??????? 
???????????????????
????????????????? 2006??
?????????????????????
???????????????[1]?????
?????????????????????
???????????(???)????? 
[2]????????????????????
?????????????????????
?????????????????????
?????????????????????
?????????????????????
?? [3-4]?????????????????
?????????????????????
?????????????????????
?????????????????????
??[5]??????????????????
?????????????????????
?????????????????????
?????????????????????
???[6]?????????????????
?????????????????????
?????(cerebral autoregulation, CA)????
?????????????????????
?????????????????????
?????????????????????
?????????????????????
?????????????????????
???????????????????[7]?
?????????????????????
?????????????????????
?????????????????????
?????????????????????
?????????????????????
?????????????????????
?????????????????????
?(detrended fluctuation analysis, DFA)?????
?????????????????????
????????????????????
?????????????????????
??????? 
 
??????? 
???????????????????
?????????????????????
??? 2??????????? 24?(66.3±9.3
?)?????????? 14?(60.8±10.0?) ?
?????? 10???? (58.4±8.0?)??? 48
???????????????? Finapres 
(Ohemda 2300) ????????? TCD 
(Transcranial Doppler ultrasound, EME TC2020) 
?????????????????????
?????????????(mean arterial blood 
pressure, MABP)???????(mean cerebral 
blood flow velocity, MCBFV)?????????
????????????????? 
 
??????? 
???????????????????
????????(long-range)????????
?????????????????????
??[8-9]: 
1.??????? Niiu ,...,3,2,1),( =  
N??????? 
2.????(1)?????? )(iu ??? )(iy   
Niujuiy
i
j
,,3,2,1,])([)(
1
L=−= ∑
=
 …...……(1) 
?? ∑
=
= N
j
ju
N
u
1
)(1 ?N?????? 
 9
0.04-0.15 Hz)????????????????
?????[11]???????????????
?????????????????????
?(p<0.05)?????(High frequency, HF:0.15~0.4 
Hz)????????(??)?????????
?????????????????????
?????????(p<0.05) (??)??????
?????????????????????
???????(sympathetic vasomotor tone)??
??????(sympathetic modulation)?????
???????????????????
[12-13]??????????????????
?????????????????????
?????????????????????
???????? 
 
??: ?????????? 
! p?0.05 (supine: normal vs. mild in LF), @ p?
0.05 (supine: normal vs. severe in LF), # p?0.05 
(tilting: normal vs. mild in LF), & p?0.05 (tilting: 
normal vs. severe in LF) 
 
??: ??????????? 
! p<0.05 (Normal: supine vs. tilting in HF), #p?
0.05 (Mild: supine vs. tilting in LF), ^ p?0.05 (Mild: 
supine vs. tilting in HF), * p?0.05 (Severe : supine 
vs. tilting in HF), @ p?0.05 (supine: normal vs. 
severe in LF), > p?0.05 (tilting: normal vs. severe 
in LF), / p?0.05 (tilting: mild vs. severe in LF) 
 
??????????? 3 ???????
????????????? 3(A)??????
??? 3(B)?????????????? 3(C)
? LogF(n)?? Log(n)????????????
?????????????????????
?????????????????????
?????????????????????
?????????????????????
?????????????????????
????(1.13?0.11 vs. 1.11?0.17, p<0.05)???
?????????????????????
??(1.11?0.17 vs. 0.93?0.24, p<0.05)?????
???(??)???????????????
????????????????????
?????????????????????
?????????????????????
?????????????????????
?????????????????????
?????????????????????
?????????????????????
?????????????????????
?????????????????????
?????????????????????
?????????? 
 
Supine Tilting MABP 
(mmHg)2 LF HF  LF HF 
Normal 
subjects  
6.54?2.06!@ 1.30?0.42  7.59?5.13#& 1.17?0.82
Diabetics 
(mild AN) 
2.83?3.32 1.63?1.23  3.61?2.72 1.48?1.15
Diabetics 
(severe AN) 
2.13?2.07 1.49?0.78  2.60?2.22 2.23?2.26
Supine Tilting MCBFV 
(cm/s)2 LF HF  LF HF 
Normal 
subjects  
4.79?5.73@ 1.71?0.93!  9.73?8.89> 3.34?2.57
Diabetics 
(mild AN) 
2.39?2.03# 2.07?1.57^  6.25?6.92/ 4.01?3.54
Diabetics 
(severe AN) 
1.56?1.55 1.50?0.51*  1.94?1.27 2.58?1.46
 1
???????????? 
???? 95-2221-E-035-004 
???? ???????????????????????? 
?????? 
??????? 
??? 
????????????(?)?? 
?????? 2007/5/20-2007/5/24, Osaka International Convention Center, Osaka, Japan 
???? The 23
rd International Symposium on Cerebral Blood Flow, Metabolism & 
Function (Brain’07) 
?????? A Novel Approach Using Higher Order Crossings to Assess Dynamic Cerebral Autoregulation in Diabetics with Autonomic Neuropathy 
 
???????? 
?????????????????????????(The 23rd International 
Symposium on Cerebral Blood Flow, Metabolism & Function (Brain’07))? 2007???????
?????????????????????????????????? Okayama 
University? National Cardiovascular Center??????????????????????
????????????????????????????? 847????? 30???
????????????????????????????????????????
?? International Conference on Quantification of Brain Function with PET (BrainPET’07)???
????????????????????????? (Meet the history of the society)??
????????????????????????????????????????
?????????????????????????????? 10????? 56??
????????????????????????????????????????
????????????????????????????????????????
??????????????????(higher order crossings)?????????????
??????????????? 1 ~ 20??????????(zero-crossings)??????
????????????????????????????????(??/??)???
?????(p?0.05)???????????????????????????????
????????????????????????????????????????
????????????????????????????????????????
????????????????????????????????????????
???????????????????????????(p?0.05)?????????
????????????????????????????????????????
?????? Poster???????????????????????????????
????????????????? 
 
 
